Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day. This move outpaced the S&P 500's daily gain of 0.13%. At the same time ...

Joining us this morning at our Cantor Global Healthcare Conference. Really excited to have another year of it. My name is Olivia Brayer. I'm a senior Biotech Analyst here at Cantor. And we're ...

and Controls (CMC) module of a potential Biologics License Application (BLA). Additionally, management’s expectation to provide further updates on the drug product PPQ campaign aligns with the ...

If you just need a basic laptop for simple tasks like browsing the internet and watching streaming shows, the affordable Dell Inspiron 15 will be enough with its Intel Core i3-1215U, Intel Xe ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Manufacturing and Controls (CMC) module.” “In achieving this commercialization milestone, we believe Opthea is well positioned to supply both our planned drug product PPQ campaign, as well as ...

The successful PPQ campaign shows Opthea's capability to consistently produce quality drug substance at a commercial scale, which is expected to be a crucial part of their BLA Chemistry, Manufacturing ...

Manufacturing and Controls (CMC) module.” “In achieving this commercialization milestone, we believe Opthea is well positioned to supply both our planned drug product PPQ ...

and Controls (CMC) module. Mark O’Neill, Vice President of Technical Operations at Opthea, added that this milestone positions the company to supply materials for both their upcoming drug ...